Skip to main content
. 2011 Nov 15;158(1):324–339. doi: 10.1104/pp.111.190280

Table II. Lipids detected by ESI MS/MS negative ion precursor ion scans, Pre 291.2, Pre 293.2, and Pre 295.2.

Supplemental Tables S3 and S4 indicate the compounds detected in a simplified form. M, Mass spectrometry abbreviation used for molecule, used to indicate the uncharged molecule.

No.a M Mass M Formula Identification Detection Methodb Identification; Evidencec
1 771 C42H78O9PN 18:3-O/16:0 PC Pre 293.2, [M + C2H3O2] Tentative; Supplemental Table S1
2 793 C44H76O9PN 18:3-O/18:3 PC Pre 293.2, [M + C2H3O2] Supplemental Table S1
3 795 C44H78O9PN 18:3-O/18:2 PC Pre 293.2, [M + C2H3O2] Supplemental Table S1
4 787 C42H78O10PN 18:3-2O/16:0 PC Pre 291.2, [M + C2H3O2] Supplemental Table S1
5 809 C44H76O10PN 18:3-2O/18:3 PC Pre 291.2, [M + C2H3O2] Supplemental Table S1
6 811 C44H78O10PN 18:3-2O/18:2 PC Pre 291.2, [M + C2H3O2] Supplemental Table S1
7 773 C42H80O9PN 18:2-O/16:0 PC Pre 295.2, [M + C2H3O2] Supplemental Table S1
8 795 C44H78O9PN 18:2-O/18:3 PC Pre 295.2, [M + C2H3O2] Supplemental Table S1
9 797 C44H80O9PN 18:2-O/18:2 PC Pre 295.2, [M + C2H3O2] Tentative; Supplemental Table S1
10 789 C42H80O10PN 18:2-2O/16:0 PC Pre 293.2, [M + C2H3O2] Supplemental Table S1
11 811 C44H78O10PN 18:2-2O/18:3 PC Pre 293.2, [M + C2H3O2] Supplemental Table S1
12 813 C44H80O10PN 18:2-2O/18:2 PC Pre 293.2, [M + C2H3O2] Tentative; Supplemental Table S1
13 729 C39H72O9PN 18:3-O/16:0 PE Pre 293.2, [M − H] Supplemental Table S1
14 751 C41H70O9PN 18:3-O/18:3 PE Pre 293.2, [M − H] Supplemental Table S1
15 753 C41H72O9PN 18:3-O/18:2 PE Pre 293.2, [M − H] Supplemental Table S1
16 745 C39H72O10PN 18:3-2O/16:0 PE Pre 291.2, [M − H] Supplemental Table S1
17 767 C41H70O10PN 18:3-2O/18:3 PE Pre 291.2, [M − H] Supplemental Table S1
18 769 C41H72O10PN 18:3-2O/18:2 PE Pre 291.2, [M − H] Supplemental Table S1
19 731 C39H74O9PN 18:2-O/16:0 PE Pre 295.2, [M − H] Supplemental Tables S1 and S2
20 753 C41H72O9PN 18:2-O/18:3 PE Pre 295.2, [M − H] Supplemental Table S1
21 755 C41H74O9PN 18:2-O/18:2 PE Pre 295.2, [M − H] Supplemental Table S1
22 747 C39H74O10PN 18:2-2O/16:0 PE Pre 293.2, [M − H] Supplemental Tables S1 and S2
23 769 C41H72O10PN 18:2-2O/18:3 PE Pre 293.2, [M − H] Tentative; Supplemental Table S1
24 771 C41H74O10PN 18:2-2O/18:2 PE Pre 293.2, [M − H] Tentative; Supplemental Table S1
25 756 C40H69O11P 18:4-O/16:1 PG Pre 291.2, [M − H] Buseman et al. (2006)
26 758 C40H71O11P 18:4-O/16:0 PG Pre 291.2, [M − H] Buseman et al. (2006)
27 758 C40H71O11P 18:3-O/16:1 PG Pre 293.2, [M − H] Supplemental Table S1
28 760 C40H73O11P 18:3-O/16:0 PG Pre 293.2, [M − H] Supplemental Table S1
29 760 C40H73O11P 18:2-O/16:1 PG Pre 295.2, [M − H] Supplemental Table S1
30 762 C40H75O11P 18:2-O/16:0 PG Pre 295.2, [M − H] Supplemental Table S1
31* 776 C40H73O12P 18:2-2O/16:1 PG Pre 293.2, [M − H] Supplemental Table S1
31* 776 C43H68O12 18:3-O/16:4-O MGDG Pre 293.2, [M − H] Supplemental Table S1
32 778 C40H75O12P 18:2-2O/16:0 PG Pre 293.2, [M − H] Supplemental Table S1
33 922 C49H78O16 18:4-O/16:3 DGDG Pre 291.2, [M − H] Supplemental Table S1
34 928 C49H84O16 18:4-O/16:0 DGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
35 936 C49H76O17 18:4-O/16:4-O DGDG Pre 291.2, [M + C2H3O2] Hisamatsu et al. (2005)
36 950 C51H82O16 18:4-O/18:3 DGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
37 964 C51H80O17 18:4-O/18:4-O DGDG Pre 291.2, [M + C2H3O2] Hisamatsu et al. (2005); Buseman et al. (2006)
38 924 C49H80O16 18:3-O/16:3 DGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
39 930 C49H86O16 18:3-O/16:0 DGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
40 938 C49H78O17 18:3-O/16:4-O DGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
41 952 C51H84O16 18:3-O/18:3 DGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
42 966 C51H82O17 18:3-O/18:4-O DGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
43 940 C49H80O17 18:3-2O/16:3 DGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
44 946 C49H86O17 18:3-2O/16:0 DGDG Pre 291.2, [M − H] Supplemental Table S1
45′ 954 C49H78O18 18:3-2O/16:4-O DGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
45′ 954 C49H78O18 18:4-O/16:3-2O DGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
46 968 C51H84O17 18:3-2O/18:3 DGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
47 982 C51H82O18 18:3-2O/18:4-O DGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
48 760 C43H68O11 18:4-O/16:3 MGDG Pre 291.2, [M − H] Supplemental Table S2; Stelmach et al. (2001); Buseman et al. (2006)
49 774 C43H66O12 18:4-O/16:4-O MGDG Pre 291.2, [M + C2H3O2] Supplemental Table S2; Hisamatsu et al. (2003); Buseman et al. (2006)
50 788 C45H72O11 18:4-O/18:3 MGDG Pre 291.2, [M − H] Buseman et al. (2006)
51 802 C45H70O12 18:4-O/18:4-O MGDG Pre 291.2, [M + C2H3O2] Supplemental Table S2; Hisamatsu et al. (2003); Buseman et al. (2006)
52 762 C43H70O11 18:3-O/16:3 MGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
53 776 C43H68O12 18:3-O/16:4-O MGDG Pre 293.2, [M + C2H3O2] Tentative; Supplemental Table S1
54 790 C45H74O11 18:3-O/18:3 MGDG Pre 293.2, [M − H] Supplemental Table S1
55 804 C45H72O12 18:3-O/18:4-O MGDG Pre 293.2, [M + C2H3O2] Supplemental Table S1
56 778 C43H70O12 18:3-2O/16:3 MGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
57 792 C43H68O13 18:3-2O/16:4-O MGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
58 806 C45H74O12 18:3-2O/18:3 MGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
59 820 C45H72O13 18:3-2O/18:4-O MGDG Pre 291.2, [M + C2H3O2] Buseman et al. (2006)
60 992 C59H92O12 18:4-O/16:3/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
61 998 C59H98O12 18:4-O/16:3/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
62 1,026 C61H102O12 18:4-O/18:3/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
63a 1,054 C63H106O12 18:4-O/18:3/18:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
63b 1,054 C63H106O12 18:4-O/18:2/18:1 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
64 1,006 C59H90O13 18:4-O/16:4-O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
65 1,010 C59H94O13 18:4-O/16:4-O/16:1 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
66 1,012 C59H96O13 18:4-O/16:4-O/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
67a 1,020 C59H88O14 18:4-O/16:4-O/16:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
67b 1,020 C61H96O12 18:4-O/18:3/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
68a 1,034 C61H94O13 18:4-O/16:4-O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
68b 1,034 C61H94O13 18:4-O/18:4-O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
69a 1,038 C61H98O13 18:4-O/16:4-O/18:1 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
69b 1,038 C61H98O13 18:4-O/18:4-O/16:1 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
70a 1,040 C61H100O13 18:4-O/16:4-O/18:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
70b 1,040 C61H100O13 18:4-O/18:4-O/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
71a 1,048 C61H92O14 18:4-O/18:4-O/16:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2; Andersson et al. (2006)
71b 1,048 C63H100O12 18:4-O/18:3/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
72a 1,062 C63H98O13 18:4-O/18:4-O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
72b 1,062 C61H90O15 18:4-O/18:5-2O/16:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
73 1,068 C63H104O13 18:4-O/18:4-O/18:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
74 1,076 C63H96O14 18:4-O/18:4-O/18:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2; Kourtchenko et al. (2007)
75 1,016 C59H100O13 18:3-2O/16:0/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
76a 1,044 C61H104O13 18:3-2O/18:3/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
76b 1,044 C61H104O13 18:3-2O/18:0/16:3 acMGDG Pre 291.2, [M + C2H3O2] Tentative; Supplemental Table S1
77a 1,072 C63H108O13 18:3-2O/18:3/18:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
77b 1,072 C61H100O15 18:3-2O/18:2/16:3-2O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
77c 1,072 C63H108O13 18:3-2O/18:2/18:1 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
78′ 1,024 C59H92O14 18:3-2O/16:4-O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
78′ 1,024 C59H92O14 18:4-O/16:3-2O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
79′ 1,030 C59H98O14 18:3-2O/16:4-O/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
79′ 1,030 C59H98O14 18:4-O/16:3-2O/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
80a′ 1,052 C61H96O14 18:3-2O/16:4-O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
80a′ 1,052 C61H96O14 18:4-O/16:3-2O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
80b 1,052 C61H96O14 18:3-2O/18:4-O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
81a 1,070 C61H98O15 18:3-2O/16:3-2O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
81b 1,070 C61H98O15 18:3-2O/18:3-2O/16:3 acMGDG Pre 291.2, [M + C2H3O2] Tentative; Supplemental Table S1
81c 1,070 C63H106O13 18:3-2O/18:2/18:2 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
82′ 1,084 C61H96O16 18:3-2O/16:3-2O/18:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
82′ 1,084 C61H96O16 18:3-2O/18:3-2O/16:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
83a 1,058 C61H102O14 18:3-2O/18:4-O/16:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
83b 1,058 C61H102O14 18:3-2O/16:4-O/18:0 acMGDG Pre 291.2, [M + C2H3O2] Tentative; Supplemental Table S1
84a 1,066 C61H94O15 18:3-2O/18:4-O/16:4-O acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
84b 1,066 C63H102O13 18:3-2O/18:3/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Tables S1 and S2
85 1,080 C63H100O14 18:3-2O/18:4-O/18:3 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
86 1,086 C63H106O14 18:3-2O/18:4-O/18:0 acMGDG Pre 291.2, [M + C2H3O2] Supplemental Table S1
a

Each number (186) represents a peak observed in triple quadrupole MS spectra (Fig. 1). An asterisk indicates peaks resulting from two compounds of different lipid classes with the same ion mass. A prime symbol indicates peaks with at least two possible identifications, where it is unclear whether the peak represents one or both compounds. Numbers followed by a, b, or c signify that accurate m/z analysis indicates that the peak represents multiple lipid species detected by the stated precursor scan (Supplemental Tables S1 and S2).

b

Peaks were identified in triple quadrupole MS spectra with three negative precursor scans, Pre 291.2, Pre 293.2, and Pre 295.2; each species was observed as the [M − H]/or [M + C2H3O2] ion.

c

QTOF MS peak data are provided in Supplemental Table S1. FTICR MS peak data are provided in Supplemental Table S2. Peak identification is indicated as “tentative” if QTOF MS m/z values for one acyl group (or more) were greater than 10 ppm from the theoretical m/z and the compound was not previously identified or identified by accurate m/z of the intact compound in FTICR MS spectra. Previously identified peaks/compounds are marked with corresponding references.